Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dolby Laboratories, Inc. (DLB) vs Procter & Gamble Co (PG) Price & Performance

Dolby Laboratories, Inc.Trade
Procter & Gamble CoTrade

Price performance (Past 24H)

Key statistics

Dolby Laboratories, Inc. vs Procter & Gamble Co — how do they compare? Dolby Laboratories, Inc. trades at $58.69 (market cap $5.47B), while Procter & Gamble Co trades at $150.94 (market cap $349.77B). The key difference: Procter & Gamble Co is far larger — about 63.9× Dolby Laboratories, Inc.'s market cap, and Procter & Gamble Co pays the higher dividend (2.89%). Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and Procter & Gamble Co for 131 Days on average.

DLBPG
Market Cap
$5.47B$349.77B
Volume
1,058,28410,055,825
Sector
TechnologyConsumer Staples
52-Week High
$70.09$167.18
52-Week Low
$48.51$138.10
Typical Hold Time
98 Days131 Days
Enterprise Value
$4.85B$375.61B
Dividend Yield
2.46%2.89%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dolby Laboratories, Inc.

DLB trades at $58.90, up 0.94% with bearish technical signals but strong fundamentals including 87.61% gross margins and consistent earnings beats. Recent expansion with Meta and leadership transition to Marc Whitten highlight growth initiatives. Cash flow improved significantly to $215.61M in 2025 from negative trends.

Analyst consensus targets $90.33 (53% upside) with 47% buy ratings, though technical indicators signal caution. Key risks include licensing volatility and execution during leadership change. Revenue stability and premium valuation at 24.87 P/E support long-term case if growth accelerates.

Procter & Gamble Co

Procter & Gamble (PG) trades at $150.87, up 2.06% today, showing strong momentum near its consensus price target of $160.13. The stock maintains a bullish technical outlook with moving averages supporting upward momentum, while fundamentals reveal consistent earnings beats and robust profitability with 18.44% net margins. Recent corporate developments include a new WNBA partnership and a $1.09 dividend declaration, reinforcing its stable income appeal.

PG offers reliable growth with three consecutive earnings beats and strong cash flow generation, though premium valuation multiples pose near-term risk. The company's supply chain enhancements and dividend track record provide stability, but investors face headwinds from soft demand concerns and elevated P/E ratios. Wall Street maintains a bullish stance with 53% buy ratings, suggesting moderate upside potential.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DLB

No sentiment data available yet.

PG
91% Buy9% Sell
Avg holding period · 131 Days

Top news

Latest headlines on both assets

About Dolby Laboratories, Inc.

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Read more on DLB →

About Procter & Gamble Co

The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.

Read more on PG →